Post‐mortem tissue donation programs as platforms to accelerate cancer research

Abstract Given recent advances in the treatment of cancer, patients are surviving longer but frequently develop treatment‐resistant and inoperable metastases. Biomedical research has advanced to the stage where in‐depth study of these lesions is feasible, with the goal of further refining our unders...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew Dankner (Author), Badia Issa‐Chergui (Author), Nathaniel Bouganim (Author)
Format: Book
Published: Wiley, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a8051a04b89c47419a442cb0acb206b7
042 |a dc 
100 1 0 |a Matthew Dankner  |e author 
700 1 0 |a Badia Issa‐Chergui  |e author 
700 1 0 |a Nathaniel Bouganim  |e author 
245 0 0 |a Post‐mortem tissue donation programs as platforms to accelerate cancer research 
260 |b Wiley,   |c 2020-07-01T00:00:00Z. 
500 |a 2056-4538 
500 |a 10.1002/cjp2.159 
520 |a Abstract Given recent advances in the treatment of cancer, patients are surviving longer but frequently develop treatment‐resistant and inoperable metastases. Biomedical research has advanced to the stage where in‐depth study of these lesions is feasible, with the goal of further refining our understanding of metastatic dissemination, therapeutic resistance and inoperable tumors. However, there is a lack of tissue specimens derived from multiple metastatic sites within the same patient that would permit the study of these processes. Furthermore, patients with rapidly progressing or metastatic disease are rarely candidates for surgery, making those most in need of innovation and discovery extremely difficult to study. For this reason, post‐mortem tissue donation programs are an approach that is quickly gaining traction in the cancer research community. Herein, we discuss what post‐mortem tissue donation entails, attitudes towards these procedures, and highlight important studies already utilizing these resources. In addition, we propose future directions for use of this tissue that can directly improve clinical management of advanced cancer patients. 
546 |a EN 
690 |a rapid autopsy 
690 |a rapid tissue donation 
690 |a post‐mortem tissue donation 
690 |a cancer research 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n The Journal of Pathology: Clinical Research, Vol 6, Iss 3, Pp 163-170 (2020) 
787 0 |n https://doi.org/10.1002/cjp2.159 
787 0 |n https://doaj.org/toc/2056-4538 
856 4 1 |u https://doaj.org/article/a8051a04b89c47419a442cb0acb206b7  |z Connect to this object online.